Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen K Doberstein

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Science Translational Medicine|March 29, 2013
Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancerThomas C Harding, Li Long, Servando Palencia, et al.
Journal of Translational Autoimmunity|May 27, 2021
NKTR-358: A novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseasesNeha Dixit, Christie Fanton, John L Langowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2016
NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor ModelsDeborah H Charych, Ute Hoch, John L Langowski, et al.
Science (New York, N.Y.)|September 27, 2003
Inactivation of TNF signaling by rationally designed dominant-negative TNF variantsPaul M Steed, Malú G Tansey, Jonathan Zalevsky, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Science Translational Medicine|March 29, 2013
Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancerThomas C Harding, Li Long, Servando Palencia, et al.
Journal of Translational Autoimmunity|May 27, 2021
NKTR-358: A novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseasesNeha Dixit, Christie Fanton, John L Langowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2016
NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor ModelsDeborah H Charych, Ute Hoch, John L Langowski, et al.
Science (New York, N.Y.)|September 27, 2003
Inactivation of TNF signaling by rationally designed dominant-negative TNF variantsPaul M Steed, Malú G Tansey, Jonathan Zalevsky, et al.
Pageof 2